Welcome. I am Jung-Woo Lee, CEO of Biobytes.
As an orthopedic surgeon, I have seen that sarcopenia is more than a consequence of aging: it poses a serious threat to older adults' health. Yet there was no innovative drug anywhere in the world to address its underlying causes.
We believed the answer lay in data. Biobytes established M-Bank, the world's first multicenter sarcopenia cohort, and uses a proprietary multi-omics AI engine to identify the biomarkers underlying the disease.
Our technology reaches beyond the laboratory. From diagnostic support AI and tailored health supplements that improve quality of life today to the discovery of first-in-class drug targets, we are working toward healthier aging. We invite you to follow and support Biobytes on this journey.